Put Options

16 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2022

Feb 08, 2023

SELL
$187.24 - $242.74 $6.57 Million - $8.52 Million
-35,100 Reduced 94.1%
2,200 $444,000
Q3 2022

Nov 10, 2022

SELL
$177.23 - $227.44 $2.84 Million - $3.64 Million
-16,000 Reduced 30.02%
37,300 $7.12 Million
Q2 2022

Aug 10, 2022

SELL
$181.58 - $368.0 $1.65 Million - $3.35 Million
-9,100 Reduced 14.58%
53,300 $9.83 Million
Q1 2022

May 16, 2022

SELL
$303.87 - $423.8 $7.78 Million - $10.8 Million
-25,600 Reduced 29.09%
62,400 $21.8 Million
Q4 2021

Feb 14, 2022

BUY
$347.28 - $421.83 $7.47 Million - $9.07 Million
21,500 Added 32.33%
88,000 $33.5 Million
Q3 2021

Nov 15, 2021

BUY
$405.61 - $524.84 $10.2 Million - $13.2 Million
25,200 Added 61.02%
66,500 $27 Million
Q2 2021

Aug 13, 2021

BUY
$372.84 - $481.5 $4.25 Million - $5.49 Million
11,400 Added 38.13%
41,300 $19.5 Million
Q1 2021

May 12, 2021

SELL
$361.28 - $504.76 $11.2 Million - $15.7 Million
-31,100 Reduced 50.98%
29,900 $11.5 Million
Q4 2020

Feb 11, 2021

BUY
$292.7 - $370.96 $1.73 Million - $2.19 Million
5,900 Added 10.71%
61,000 $22.6 Million
Q3 2020

Nov 12, 2020

BUY
$268.51 - $400.74 $2.69 Million - $4.01 Million
10,000 Added 22.17%
55,100 $17 Million
Q2 2020

Jul 31, 2020

SELL
$256.46 - $373.01 $3.82 Million - $5.56 Million
-14,900 Reduced 24.83%
45,100 $16.7 Million
Q1 2020

May 01, 2020

BUY
$209.2 - $335.53 $10.3 Million - $16.4 Million
49,000 Added 445.45%
60,000 $16.4 Million
Q3 2019

Nov 14, 2019

SELL
$266.84 - $378.23 $2.11 Million - $2.99 Million
-7,900 Reduced 41.8%
11,000 $3.35 Million
Q2 2019

Aug 14, 2019

SELL
$300.59 - $368.15 $2.13 Million - $2.61 Million
-7,100 Reduced 27.31%
18,900 $6.96 Million
Q1 2019

May 14, 2019

BUY
$272.57 - $321.18 $5.72 Million - $6.74 Million
21,000 Added 420.0%
26,000 $8.08 Million
Q2 2017

Aug 14, 2017

BUY
N/A
5,000
5,000 $868,000

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $22B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.